Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Read on to learn more about the signs of psoriasis on your feet and how it can be treated. Plaque psoriasis is the most common type of psoriasis. It makes up about 90% of cases. It’s also known ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 (GLP-1) agonists in the medical world. Eli Lilly ( LLY -0.50%) has emerged ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

Can-Fite BioPharma (CANF) initiated a pivotal phase 3 psoriasis study of its oral drug Piclidenoson with the U.S. Food and Drug Administration ...

The researchers highlighted that psoriasis is a systemic condition linked to various comorbidities, emphasizing the ...

It’s not known whether Cosentyx (secukinumab) is safe to receive while pregnant or breastfeeding. Certain factors may ...